Results 291 to 300 of about 181,578 (308)

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Cell Transplantation, 2021
Feng Zhu, Guoqing Wei, Wenjun Wu
exaly  

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Molecular Therapy, 2017
Robbie G Majzner, Kelsey M Wanhainen, Terry J Fry   +2 more
exaly  

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Molecular Therapy, 2018
Hua Jiang, Zonghai Li
exaly  

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy

OncoImmunology, 2020
Anja Feldmann, Ralf Bergmann, Stefanie Koristka   +2 more
exaly  

Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells

MAbs, 2019
Diana Darowski, Sebastian Kobold, Christian Jost   +2 more
exaly  

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Molecular Therapy, 2019
Janos L Tanyi, Simon F Lacey, Michael C Soulen   +2 more
exaly  

Chimeric Antigen Receptor (CAR)

2015
Astrid Holzinger, Jennifer Makalowski, Hinrich Abken   +2 more
openaire   +1 more source

Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells

Molecular Therapy, 2017
Malika Hale, Karen Sommer, Andrew M Scharenberg   +2 more
exaly  

<p>Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer</p>

OncoTargets and Therapy, 2019
Biao Tang
exaly  

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity

Proceedings of the National Academy of Sciences of the United States of America, 2018
Hm Prince, Paul A Beavis, Michael H Kershaw   +2 more
exaly